MARIANNE EGGERL: Open Payments
NPI 1932503265 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 32 payments from 12 companies in 2025. Trend: 2023 $355 · 2024 $491 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 10 | $181 |
| Astellas Pharma US Inc | 3 | $78 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| MILLICENT US INC | 3 | $44 |
| Exact Sciences Corporation | 1 | $33 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
Products named: ZURZUVAE, Veozah, Qelbree, INTRAROSA, Mirena, Cologuard Collection Kit, Phexxi, MYFEMBREE.
Industry payments across MD — which companies pay providers there.
